Share this postLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech www.mendelspod.comCopy linkFacebookEmailNoteOtherMendelspod PodcastLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech 8Share this postLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech www.mendelspod.comCopy linkFacebookEmailNoteOther1×Preview0:00-8:12Audio playback is not supported on your browser. Please upgrade.Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech Theral TimpsonSep 13, 2023∙ Paid8Share this postLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech www.mendelspod.comCopy linkFacebookEmailNoteOtherShareChapters:0:00 World’s longest oligo8:45 Why is it difficult to synthesize long DNA?12:00 Proprietary TdT conjugate16:00 A billion-dollar market24:20 The computation model and its challenges28:35 More customers using generative AIMendelspod is now reader supported. Please consider upgrading to a paid subscription for the price of a couple cof…SubscribeShare this discussionLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech www.mendelspod.comCopy linkFacebookEmailNoteOtherComments on this episode are for paid subscribersSubscribeAlready a paid subscriber? Sign inMendelspod PodcastOffering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.SubscribeListen onSubstack AppApple PodcastsRSS FeedAppears in episodeTheral TimpsonRecent Episodes34:21Mapping the Meta Proteome: John Shon, CTO, Serimmune Dec 5 • Theral Timpson26:21Supercharged Killer Cells Effective Against Alzheimer’s: Paul Song, CEO, NKGen BiotechNov 28 • Theral Timpson32:34Chris Hall and Rich Chen of Personalis on Next Gen MRD TestingNov 21 • Theral Timpson59:11State of Sequencing 2023: Shawn Baker and Keith RobisonNov 14 • Theral Timpson43:11Newborn Sequencing 2023 Part II: What Evidence Is Enough?Nov 7 • Theral Timpson32:19Lincoln Nadauld on the State of Precision Medicine in 2023Oct 17 • Theral Timpson18:37Nothing Is "Undruggable:" Alex Federation, CEO, Talus BioOct 12 • Theral Timpson19:15Mass Spec Advances in a New Age of Proteomics: Rosy Lee, Thermo Fisher Scientific Oct 10 • Theral Timpson
Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech
Comments on this episode are for paid subscribers